TREATMENT PARAMETERS

CAUTION: The user manual of this device has to be observed!

Zoom ST handpiece
TATTOO removal – Treatment recommendation Notes
Wave- Spot size
Color Fluence [J/cm²] Speed [Hz]
length [mm]
 Only treat an area in the size of a palm within one session
3 0.8 1
 Pre-treatment: clean and degrease the treatment area
Black 1064 nm 4 0.7 1  Precooling of the treatment area is very important to reduce side effects and pain
 It is possible to use superficial anesthesia
5 0.55 1
 Start treatment with test shot to determine treatment parameters
3 0.8 1  Clinical endpoint: slight “frosting” (will disappear after less than 15 minutes
 Pinpoint bleeding is an indicator for overtreatment, in that case reduce the fluence
Blue 1064 nm 4 0.7 1
 Always use the handpiece perpendicular and in slight contact with the skin (distance holder)
5 0.55 1  Wait 4 to 6 weeks until proceeding treatment
3 1.0 1  Total number of sessions: average 6 – 10, sometimes up to 15 treatments

Green 1064 nm 4 0.85 1

5 0.75 1
3 0.45 1 CAUTION: Sudden change of color possible! In that case, do another treatment.
Red 532 nm 4 0.35 1
5 0.3 1
PERMANENT MAKE-UP removal – Treatment recommendation Notes
3 0.6 1
Black 1064 nm 4 0.5 1
 See Tattoo removal notes
5 0.4 1  Always perform test-treatment to estimate skin and pigment reactions (color change possible)
3 0.45 1
CAUTION: Sudden change of color possible! In that case, do another treatment.
Red 532 nm 4 0.35 1
5 0.3 1

8169499011-V02-20Mar2020-Para-PicoStar-EN www.asclepion.com Page 1 / 3

 TREATMENT PARAMETERS
CAUTION: The user manual of this device has to be observed!

Zoom ST handpiece
PIGMENT removal – Treatment recommendation Notes
Wave- Spot size
Indication Fluence [J/cm²] Speed [Hz]
length [mm]  Observation by a doctor (checkup + photo documentation)
 Cleaning, degreasing of the treatment area
Becker  Pre-cooling 5-10 min. (Cool pad 4-8 °C)
532 nm 3/4/5 0.9 / 0.75 / 0.65 1  Perform 3 test spots (0.15; 0.25; 0.35 J/cm²)
Nevus
 Always use the handpiece perpendicular and in slight contact with the skin (distance holder)
 Clinical endpoint: powder, sugar, whitening
Freckles 532 nm 2/3/4/5 0.8 / 0.5 / 0.35 / 0.3 1  Sign for overtreatment: flat whitening, edema, pinpoint bleeding
 Post-cooling 5-10 min. (Cool pad 4-8 °C)
 Drying ointment (zinc) to improve heeling
Pigm.  Exfoliation within 2-3 weeks
532 nm 2/3/4/5 0.7 / 0.4 / 0.3 / 0.25 1
Nevus  Sun protection factor (50+) for 6 month
 Max. 3 treatments; interval 4 weeks
Lentigo 532 nm 2/3/4/5 0.7 / 0.35 / 0.25 / 0.25 1

Nevus
1064 nm 3/4/5 0.85 / 0.7 / 0.6 1
Ota  See notes above
 Perform 3 test spots (0.5; 0.65; 0.8 J/cm²)
Café-aut-  Clinical endpoint: greyish color change
1064 nm 3/4/5 1.3 / 1.1 / 0.8 1
lait  Sign for overtreatment: whitening, pinpoint bleeding

Hyperpig.
1064 nm 2/3/4/5 1.2 / 0.9 / 0.75 / 0.65 1
Scar

8169499011-V02-20Mar2020-Para-PicoStar-EN www.asclepion.com Page 2 / 3

 TREATMENT PARAMETERS
CAUTION: The user manual of this device has to be observed!

Zoom ST handpiece
AGING SKIN – Treatment recommendation Notes
Wave- Spot size  Cleaning, degreasing of the treatment area
Indication Fluence [J/cm²] Speed [Hz]
length [mm]  Clinical endpoint: erythema, edema
 Sign for overtreatment: whitening, greyish, pinpoint bleeding
 Don’t treat pigments!
Whitening/  Permanent movement (rotation) of the handpiece across the treatment area
 Always use the handpiece perpendicular and in slight contact with the skin (distance holder)
Bleaching 1064 nm 5 0.5 – 1 10  Cleaning/cooling mask recommended after treatment
(2 min/ AE)  3-5 treatments; interval 2 weeks

 See Whitening notes

Tightening  Clinical endpoint: erythema, edema
1064 nm 5 0.25 – 0.5 5 - 10
(800 shots/AE)  Sign for overtreatment: whitening, greyish, pinpoint bleeding

Scar 3 1 – 1.5 2-5  See Whitening notes

tightening 1064 nm 4 1 – 1.5 2-5  Clinical endpoint: erythema, edema, slight erosion, slight bruising
 Sign for overtreatment: whitening, greyish, pinpoint bleeding
(20 passes) 5 1 – 1.5 2-5

8169499011-V02-20Mar2020-Para-PicoStar-EN www.asclepion.com Page 3 / 3